Skip to main content
. 2022 Jul 19;13:935390. doi: 10.3389/fendo.2022.935390

Figure 2.

Figure 2

Prevalence of different metabolic dysfunction-associated fatty liver disease (MAFLD) subgroups (A). Prevalence of left ventricular diastolic dysfunction according to MAFLD subtypes (B). Prevalence of left ventricular diastolic dysfunction according to the degree of hepatic steatosis (C). p for trend by chi-square test for linear-by-linear association.